- The use of SRA quickly and reliably reveals atrial fibrillation as the main trigger after TIA (transient ischemic attack).
- A UK study indicates the best importance of TIA detection for further TIA and stroke prevention
Numbness or paralysis of the hands, arms, legs or even half of the body, speech and vision disorders, and dizziness or difficulty walking: these disorders develop quickly, last only for a short time, and then disappear again. Transitory ischemic attack (TIA) usually has the same characteristics and causes as stroke and should be taken as a precaution. After the symptoms subside, usually within an hour, the triggers remain and not only further TIA, but also a stroke may follow soon.
For this reason, on the occasion of Germany-wide Action Day against Stroke (May 10), Apolex Medical Technologies GmbH is pointing to the urgent need to look into the causes of TIA to eradicate them. With its Stroke Risk Analysis SRA, the German-based medical technology company offers a software-based solution that helps to quickly and reliably detect atrial fibrillation (A-fib), which is difficult to identify, the most important risk factor for TIA. As and stroke, so that counter measures can be initiated.
“Ministerstroke” is a serious declaration
About one in three strokes is announced in advance by the TIA; For this reason it is commonly called “ministerstroke”. After such an event, the trigger must be determined as quickly and reliably as possible in order to be able to take timely action against another TIA or stroke. This is especially true of A-fib as a major driver of cardioembolism, meaning a blockage in a blood vessel that travels from the heart to the arteries. For example, the risk of stroke in TIA patients with A-Five can be reduced by up to two-thirds using anticoagulants.
In such cases, Apoplex Medical Technologies offers SRA, a telemedical procedure based on conventional ECG recording. The method uses an algorithm to detect A-fib, even if it only occurs randomly, suddenly and without the patient noticing. As part of secondary prevention, i.e. to avoid a second stroke after the first stroke, SRA is already being used successfully in the stroke units of more than 200 hospitals across Europe.
A recent study in England now confirms the high importance of the immediate use of automated continuous ECG monitoring in TIA patients through methods such as SRA, both in the A-Fib detection rate and the risk of recurrence of TIA or stroke. Months
The results of the research conducted by the famous Charing Cross Hospital – Imperial College Healthcare NHS Trust can be found here: https://pubmed.ncbi.nlm.nih.gov/35110330
 D’Ana L, Sikder O, Lim S, Kalladka D, Banerjee S. Detection of atrial fibrillation using an automated electrocardiographic observation in a transient ischemic attack service. BMJ Open Qual. February 2022; 11 (1): e001433. doi: 10.1136 / bmjoq-2021-001433. PMID: 35110330; PMCID: PMC8811557
Additional information about Apolex Medical Technology
Apoplex Medical Technologies GmbH was founded in 2004 in Pirmasen, West Palatinate, Germany, and specializes in new and innovative stroke prevention products for medical use worldwide. A subsidiary of Geratherm Medical AG, it focuses on an easy-to-use and effective method of so-called patient screening using medical technology applications for the prevention of stroke and vascular dementia. The SRA (Stroke Risk Analysis) method is the first usable screening method for paroxysmal atrial fibrillation. Versions available for use in stroke units and physician surgeries. Apoplex Medical Technology is supported by a wide range of academic and clinical networks that complement its core competencies in mathematics, physics and medicine. More information is available at https://apoplexmedical.com.
Phone +49 6331 698998-0